Noninvasive monitoring for methotrexate hepatotoxicity

Br J Dermatol. 2005 Mar;152(3):405-8. doi: 10.1111/j.1365-2133.2005.06605.x.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Chemical and Drug Induced Liver Injury*
  • Dermatologic Agents / adverse effects*
  • Drug Monitoring / methods*
  • Humans
  • Methotrexate / adverse effects*
  • Psoriasis / drug therapy

Substances

  • Dermatologic Agents
  • Methotrexate